Prevalence of latent tuberculosis infection among patients with interstitial lung disease requiring immunosuppression.
Vitor Loureiro DiasKarin Mueller StorrerPublished in: Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia (2022)
Patients with ILD who are treated with immunosuppressants are not commonly screened for LTBI, despite being under a greater risk of progression to active disease. This study suggests the need for a more cautious approach to these patients.
Keyphrases
- interstitial lung disease
- systemic sclerosis
- end stage renal disease
- newly diagnosed
- rheumatoid arthritis
- chronic kidney disease
- idiopathic pulmonary fibrosis
- ejection fraction
- mycobacterium tuberculosis
- prognostic factors
- risk factors
- peritoneal dialysis
- hiv aids
- human immunodeficiency virus
- pulmonary tuberculosis
- adverse drug
- patient reported